Emergency pharmacy order - lenalidomide 15MG and 2.5MG
Ended Awarded Last action
- Contract number
- 36C26125N0696
- Awardee
-
Exelan Pharmaceuticals Inc. UEI FYZXNHSQTMG8
- Awarding agency
-
Veterans Integrated Service Network 21
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $10,397
Award facts
- Contract value 100% obligated
- $10,397.48 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Boca Raton, FL 33432, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$13,501 | |
| Original award | $23,898 |
About this award
The Department of Veterans Affairs Veterans Integrated Service Network 21 awarded an emergency delivery order to Exelan Pharmaceuticals Inc. on August 27, 2025, for the procurement of Lenalidomide in 15mg and 2.5mg formulations. This firm fixed-price contract, valued at $10,397.48, was funded through fiscal year 2025 Defense and Overseas Contingency Operations (DEOB) appropriations and carries an ultimate completion date of September 30, 2025. The award was issued without a set-aside designation, allowing Exelan to compete openly. Performance will take place at the contractor's facility in Boca Raton, Florida. This delivery order falls under the GSA Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), which enables federal agencies to obtain pharmaceutical products and services through pre-established contract vehicles.
Exelan Pharmaceuticals Inc., a foreign-owned pharmaceutical company specializing in manufacturing, distributing, and repackaging generic and branded medications, is well-positioned as a federal contractor with extensive experience serving the VA, Department of Defense, Bureau of Prisons, and Indian Health Service. The company holds multiple indefinite delivery contracts with the VA National Acquisition Center and Defense Logistics Agency, with contract values ranging from millions of dollars. This emergency order for Lenalidomide, a critical pharmaceutical used in cancer treatment regimens, reflects the VA's reliance on Exelan's established supply chain capabilities to rapidly fulfill urgent healthcare requirements for veteran beneficiaries.
Quick answers
Who was awarded contract 36C26125N0696?
36C26125N0696 was awarded to Exelan Pharmaceuticals Inc. by Veterans Integrated Service Network 21 (Veterans Health Administration) on August 27, 2025.
How much is contract 36C26125N0696 worth?
The government has obligated $10,397 on 36C26125N0696.
Is contract 36C26125N0696 an order under another contract?
Yes. 36C26125N0696 is a delivery order under 36F79720D0227, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26125N0696 competed?
The extent of competition for 36C26125N0696 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award